NL-OMON28908招募中不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder.
KI-Av0 个研究点目标入组 31 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 31
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Signed written informed consent;
- •2. Histologically confirmed bladder carcinoma stage (including previous treatment):
排除标准
- •1. Evidence of M+ (all patients will undergo a pelvic lymphadenectomy prior to chemoradiation);
- •2. Prior chemotherapy or radiotherapy to the pelvis;
研究者
相似试验
已完成
不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder10004994Bladder carcinomabladder cancerNL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
已完成
1 期
Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckNCT03635164University of Colorado, Denver21
招募中
1 期
Phase I study for simultaneous radiochemotherapy of relapsed ovarian cancerC51-C58Malignant neoplasms of female genital organsDRKS00008552niversitätsklinikum für Strahlentherapie6
招募中
1 期
Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCCLocally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell CarcinomaNCT05085496City of Hope Medical Center12
Unknown
1 期
Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal CancerRectal CancerNCT01716949University of Erlangen-Nürnberg Medical School59